Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1806 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02 |
filingDate |
2001-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2004506025-A |
titleOfInvention |
Use of perfluoroalkyl-containing metal complexes as contrast agents in MR-imaging for imaging plaque, tumor and necrosis |
abstract |
The present invention, the critical micelle formation concentration <10 - 3 mol / l, hydrodynamic micelle diameter (2Rh)> 1nm and proton relaxation in plasma (R 1)> perfluoroalkyl-containing metal having a 10 l / mmol ยท s The invention relates to the use of perfluoroalkyl-containing metal complexes as contrast agents in MR-imaging for imaging plaques, lymph nodes, infarcted and necrotic tissues and for independently imaging necrotic and tumor tissues. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7037069-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680037-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018052037-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104639-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011190183-A |
priorityDate |
2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |